NEVRO CORP. Deferred Tax Assets, Gross
NEVRO CORP. had Deferred Tax Assets, Gross of $238.91 million as of 2024-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2025-03-04
- 2024-12-31: Deferred Tax Assets, Gross $238.91M.
- 2023-12-31: Deferred Tax Assets, Gross $216.08M.
- 2022-12-31: Deferred Tax Assets, Gross $204.91M.
- 2021-12-31: Deferred Tax Assets, Gross $206.08M.
| Period end | Deferred Tax Assets, Gross |
|---|---|
| 2024-12-31 | $238.91M 10-K · filed 2025-03-04 |
| 2023-12-31 | $216.08M 10-K · filed 2025-03-04 |
| 2022-12-31 | $204.91M 10-K · filed 2024-02-23 |
| 2021-12-31 | $206.08M 10-K · filed 2023-02-21 |
| 2020-12-31 | $169.77M 10-K · filed 2022-02-23 |
| 2019-12-31 | $138.16M 10-K · filed 2021-02-24 |
| 2018-12-31 | $101.68M 10-K · filed 2020-02-25 |
| 2017-12-31 | $88.12M 10-K · filed 2019-02-21 |
| 2016-12-31 | $85.73M 10-K · filed 2018-02-22 |
| 2015-12-31 | $67.38M 10-K · filed 2017-02-23 |
| 2014-12-31 | $43.67M 10-K · filed 2016-02-29 |
| 2013-12-31 | $34.27M 10-K · filed 2016-02-29 |
| 2012-12-31 | $24.31M 10-K · filed 2015-03-18 |